Moderna

Metagenomi can’t ax IPO investor suit over Moderna partnership Bloomberg Law18:25Flotations/IPOs

US drug regulator to review Moderna's mRNA flu vaccine after rejection Anadolu Agency16:37mRNA FDA Moderna Vaccine

Moderna, Pfizer press to toss Bayer’s covid-shot patent suits Bloomberg Law18:47mRNA Patent Law Coronavirus Vaccine

Bank of America flags international opportunities as key growth driver for Moderna Proactive Investors (US)18:07Stock Markets (World) Moderna Vaccine Bank of America

Moderna (MRNA) stock declines while market improves: Some information for investors Zacks23:58S&P 500 Stock Markets (World) Stock Market (US)

Moderna (MRNA) stock dips while market gains: Key facts Zacks23:59S&P 500 Stock Markets (World) Stock Market (US)

Moderna (MRNA) falls more steeply than broader market: What investors need to know Zacks22:59S&P 500 Stock Markets (World) Stock Market (US)

Moderna (MRNA) suffers a larger drop than the general market: Key insights Zacks23:00S&P 500 Stock Markets (World) Stock Market (US)

Moderna stock is soaring. Is it too late to buy? The Motley Fool19:42Coronavirus Vaccine Moderna Vaccine Biotechnology

Moderna is most shorted S&P 500 stock now. Is it a contrarian buy? Barchart15:10S&P 500 Stock Markets (World) Stock Market (US)

Latest News

Yesterday

Hackers claim breach exposing Moderna, J&J, Bayer employee data CyberNews14:04 10-Apr-26

In the last 7 days

Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors Zacks23:58 9-Apr-26

Moderna eyes international markets as growth driver, says Bank of America Proactive Investors (US)18:28 8-Apr-26

Bank of America flags international opportunities as key growth driver for Moderna Proactive Investors (US)18:07 8-Apr-26

Moderna Is Most Shorted S&P 500 Stock Now. Is It a Contrarian Buy? Barchart15:10 8-Apr-26

US drug regulator to review Moderna's mRNA flu vaccine after rejection Anadolu Agency16:37 7-Apr-26

Life Sciences Ontario Welcomes New Board Members in 2026 Following Annual General Meeting Business Wire (Press Release)13:08 7-Apr-26

Moderna Museet debuts Sweden's first major Brassaï survey ArtDaily03:01 6-Apr-26

In the last month

Moderna (MRNA) Stock Dips While Market Gains: Key Facts Zacks23:59 2-Apr-26

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know Barchart20:32 2-Apr-26

The Vaccine Industry Is Troubleshooting Its Future Existence NOTUS10:58 2-Apr-26

Moderna, Pfizer Want Bayer's COVID-Shot Patent Suits Tossed Law36002:40 1-Apr-26

Moderna, Pfizer Press to Toss Bayer’s Covid-Shot Patent Suits Bloomberg Law18:47 31-Mar-26

Moderna (MRNA) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks22:59 27-Mar-26

ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential? Zacks14:19 27-Mar-26

Is Moderna (MRNA) Attractive After A 73% Year To Date Share Price Jump? Simply Wall St17:39 26-Mar-26

Moderna Stock is Soaring. Is It Too Late to Buy? The Motley Fool19:42 25-Mar-26

Metagenomi Can’t Ax IPO Investor Suit Over Moderna Partnership Bloomberg Law18:25 25-Mar-26

Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights Zacks23:00 20-Mar-26

Pfizer vs Moderna: Which Pharma Stock Has More Upside? The Motley Fool19:42 19-Mar-26

Moderna CEO Stéphane Bancel’s 2025 pay hits $19.9M as cash bonus more than doubles FiercePharma16:14 17-Mar-26

GSK’s RSV jab secures FDA label expansion to larger adult population Pharmaceutical Technology12:18 16-Mar-26

Moderna (MRNA) Declines More Than Market: Some Information for Investors Zacks22:53 13-Mar-26

Moderna (MRNA) Valuation Check After Sharp Multi‑Month Share Price Rebound Simply Wall St22:08 13-Mar-26

Quo Vadis mRNA Vaccine Technology? The State of the IP Lawsuits JD Supra19:48 13-Mar-26

Moderna Settles Patent Litigation with Arbutus et al. JD Supra13:07 11-Mar-26

view more headlines

10 Apr 14:04

About our Moderna news

Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.